Mersana Therapeutics, Inc. (MRSN): Price and Financial Metrics


Mersana Therapeutics, Inc. (MRSN)

Today's Latest Price: $5.83 USD

0.73 (-11.13%)

Updated Mar 31 8:00pm

Add MRSN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 337 in Biotech

See all "A" rated Strong Buy stocks

MRSN Stock Summary

  • Mersana Therapeutics Inc's stock had its IPO on June 28, 2017, making it an older stock than just 8.19% of US equities in our set.
  • Revenue growth over the past 12 months for Mersana Therapeutics Inc comes in at 297.61%, a number that bests 97.96% of the US stocks we're tracking.
  • The volatility of Mersana Therapeutics Inc's share price is greater than that of 96.35% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Mersana Therapeutics Inc, a group of peers worth examining would be LQDA, PIRS, ORMP, KALV, and CDTX.
  • Visit MRSN's SEC page to see the company's official filings. To visit the company's web site, go to www.mersana.com.
MRSN Daily Price Range
MRSN 52-Week Price Range

MRSN Stock Price Chart More Charts


MRSN Price/Volume Stats

Current price $5.83 52-week high $9.57
Prev. close $6.56 52-week low $1.32
Day low $5.24 Volume 1,624,800
Day high $6.36 Avg. volume 512,871
50-day MA $7.26 Dividend yield N/A
200-day MA $4.24 Market Cap 264.86M

Mersana Therapeutics, Inc. (MRSN) Company Bio


Mersana Therapeutics, Inc. is a biotechnology company that discovers, engineers, and develops antibody drug conjugates to cure various cancers. The company develops immune conjugate therapies to create drugs that enhance patients’ lives. It offers XMT-1522, a drug therapy for tumor models that express relatively low amounts of the HER2 protein; and human anti-HER2 antibody used in XMT-1522. Mersana Therapeutics, Inc. has strategic alliances with Takeda Pharmaceutical Company Limited; Merck Serono; and Asana BioSciences. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was founded in 2001 and is based in Cambridge, Massachusetts.


MRSN Latest News Stream


Event/TimeNews Detail
Loading, please wait...

MRSN Latest Social Stream


Loading social stream, please wait...

View Full MRSN Social Stream

MRSN Price Returns

1-mo -35.65%
3-mo 8.77%
6-mo 286.09%
1-year 12.55%
3-year N/A
5-year N/A
YTD 1.75%
2019 40.44%
2018 -75.17%
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.0659 seconds.